Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and immunogenicity of a Clostridioides difficile toxoid vaccine in healthy elderly volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Clostridioides difficile toxoid vaccine (Clostridioides difficile toxoid vaccine)

Snippet

Sponsor: Sanofi | Conditions: Clostridium Infections | Phase 1 | Status: COMPLETED | Results posted: 2012-04-09